Korea S.E.
06:00:00 2024-04-17 pm EDT
5-day change
1st Jan Change
8,700
KRW
+1.52%
+0.46%
-5.43%
Tranche Update on Seoulin Bioscience Co.,Ltd.'s Equity Buyback Plan announced on August 8, 2019.
February 10, 2020 at 03:34 am EST
From August 8, 2019 to February 8, 2020, the company has repurchased 92,246 shares, representing 1.2% for KRW 802.37 million. With this, the company has completed the repurchase of 92,246 shares, representing 1.2% for KRW 802.37 million under the buyback announced on August 8, 2019.
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Mar. 20
CI
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Nov. 13
CI
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
23-08-11
CI
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
23-05-15
CI
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
23-03-15
CI
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
22-11-14
CI
Seoulin Bioscience Co.,Ltd.(KOSDAQ:A038070) dropped from S&P Global BMI Index
22-09-19
CI
Light Farm Tech Co., Ltd. announced that it has received KRW 1.999995 billion in funding from Seoulin Bioscience Co.,Ltd.
22-08-07
CI
Light Farm Tech Co., Ltd. announced that it expects to receive KRW 1.999995 billion in funding from Seoulin Bioscience Co.,Ltd. and other investors
22-07-21
CI
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
22-05-16
CI
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
22-03-10
CI
Seoulin Bioscience Co.,Ltd. announced that it has received KRW 30 billion in funding from Shinhan Investment Corp., Investment Arm, Hanyang Securities Co., Ltd., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm, Mirae Asset Capital Co,Ltd., Investment Arm, Cornerstone Investment Partners Co., Ltd., and other investors
21-11-23
CI
Seoulin Bioscience Co.,Ltd. announced that it expects to receive KRW 30 billion in funding from Shinhan Investment Corp., Investment Arm, Hanyang Securities Co., Ltd., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm, Mirae Asset Capital Co,Ltd., Investment Arm, Cornerstone Investment Partners Co., Ltd., and other investors
21-11-21
CI
Seoulin Bioscience Co.,Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
21-11-14
CI
Seoulin Bioscience Co.,Ltd.(KOSDAQ:A038070) added to S&P Global BMI Index
21-09-20
CI
Seoulin Bioscience Co.,Ltd.'s Equity Buyback announced on June 11, 2019, has expired.
20-06-11
CI
Tranche Update on Seoulin Bioscience Co.,Ltd.'s Equity Buyback Plan announced on August 8, 2019.
20-02-10
CI
Seoulin Bioscience Co.,Ltd.'s Equity Buyback announced on August 8, 2019, has expired with 92,246 shares, representing 1.2% for KRW 802.37 million.
20-02-07
CI
Seoulin Bioscience Co.,Ltd. announces an Equity Buyback for KRW 1,000 million worth of its shares.
19-08-08
CI
Seoulin Bioscience Co.,Ltd. authorizes a Buyback Plan.
19-08-07
CI
Seoulin Bioscience Co.,Ltd. announces an Equity Buyback for KRW 2,000 million worth of its shares.
19-06-10
CI
Seoulin Bioscience Co.,Ltd. authorizes a Buyback Plan.
19-06-10
CI
SeouLin Bioscience Co., Ltd. to Distribute Cellular Dynamics International, Inc.'s Products in Korea
15-08-20
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Seoulin Bioscience Co., Ltd is a Korea-based company engaged in the developing and manufacturing of basic equipment for bio research. The Company mainly engages in research and development of reagents, such as deoxyribonucleic acid (DNA) chips, which are used for gene therapy, clinical diagnosis, organs transplantation and biopsy; stem cells, which are used for treatment of incurable diseases, Alzheimer disease and others, and next-generation biotechnology drugs. The company supplies its products under the brand name MyLab. It also imports bio research equipment from Thermo Fisher, Affymetrix, Sarstedt and others, and markets in the domestic market. In addition, the Company engages in the real estate rental business.
More about the company
1st Jan change
Capi.
-5.43% 54.11M -1.82% 41.35B +41.98% 40.38B +2.56% 39.05B -12.11% 26.67B +3.09% 24.07B -24.16% 18.36B +22.12% 11.6B -3.74% 11.68B +7.75% 11.15B
Other Biotechnology & Medical Research
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
SEOULIN BIOSCIENCE CO.,LTD. 
